Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How I treat priapism.

Uzoma A Anele1, Brian V Le1, Linda M S Resar2

  • 1The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD;

Blood
|March 27, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periprocedural anti-thrombotic therapy and priapism recurrence after surgical shunting: a propensity-matched analysis.

The journal of sexual medicine·2026
Same author

Predicting major ischemic priapism: a novel dynamic nomogram based on recurrent ischemic priapism risk factors.

The journal of sexual medicine·2026
Same author

Changes in sexual quality of life in patients with stress urinary incontinence treated with an artificial urinary sphincter; analysis of the artificial urinary sphincter clinical outcomes trial (AUSCO).

The journal of sexual medicine·2026
Same author

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.

Blood advances·2026
Same author

Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

Safety and tolerability of a novel implantable neurostimulator to improve erectile function: a pilot study in patients with spinal cord injury.

The journal of sexual medicine·2026

Priapism, a persistent erection, frequently affects sickle cell disease (SCD) patients, risking erectile dysfunction. New research explores molecular targets for preventing this serious complication.

Area of Science:

  • Urology
  • Hematology
  • Molecular Pathophysiology

Background:

  • Priapism is a prolonged erection unrelated to sexual stimulation.
  • Ischemic priapism can lead to severe complications, including erectile dysfunction.
  • Patients with hematologic disorders, particularly sickle cell disease (SCD), have a high prevalence of priapism.

Purpose of the Study:

  • To highlight the critical need for timely diagnosis and management of SCD-associated priapism.
  • To review current reactive treatment strategies.
  • To explore emerging therapeutic targets based on a deeper understanding of the molecular pathophysiology.

Main Methods:

  • Review of current literature and clinical guidelines.
  • Analysis of the molecular mechanisms underlying SCD-associated priapism.

Related Experiment Videos

  • Identification of potential targets for novel therapeutic agents.

    • Main Results:

    • Current management primarily focuses on reactive treatments for priapism.
    • Understanding the molecular basis of SCD-priapism is advancing.
    • New therapeutic targets are being identified for potential preventive therapies.

    Conclusions:

    • Timely intervention is crucial to mitigate cavernosal tissue damage in priapism episodes.
    • Novel preventive strategies targeting molecular pathways are under development for SCD-associated priapism.
    • Future research aims to shift focus from reactive treatment to proactive prevention.